@LinkedInHelp ’ve had two accounts restricted for a long time. I’ve tried verifying them with my ID multiple times, but it hasn’t worked.
Please help me permanently delete those accounts so I can create a new one and use LinkedIn properly. Thank you.
ChatGPT + laptop + internet connection + 60 minutes per day = $9500 every month.
I normally sell this guide for $81, but for the next 48 hours, it’s yours 100% FREE.
To get: -
1. Follow me (So I can DM you )
2. Retweet
3. Reply " Ai "
Must follow me to get DM. Free for 48 hours
ChatGPT + laptop + internet connection + 60 minutes per day = $9500 every month.
I normally sell this guide for $81, but for the next 48 hours, it’s yours 100% FREE.
To get: -
1. Follow me (So I can DM you )
2. Retweet
3. Reply " Ai "
Must follow me to get DM. Free for 48 hours
Avalanche is a Layer 1 blockchain designed for speed, scalability, and flexibility, using a multi-chain structure, high transaction throughput, and rapid finality to support Web3 applications, smart contracts, and decentralized platforms.
Microblog @antgrasso#Blockchain#Web3
Avalanche's architecture consists of three chains—X-Chain for asset transactions, P-Chain for staking and validation, and C-Chain for smart contracts—optimizing performance while maintaining decentralization.
With the ability to process over 4,500 transactions per second, it offers a scalable environment for enterprises and developers.
Its subnet technology enables the creation of customizable blockchains tailored to specific needs, while Proof of Stake ensures energy efficiency.
Supporting Ethereum-compatible smart contracts, Avalanche fosters seamless app deployment, making it a strong choice for DeFi, NFTs, gaming, and enterprise solutions.
#Avalanche #AVAX #Crypto #DeFi #SmartContracts #NFTs #Decentralization #ProofOfStake #FinTech
DID YOU KNOW THERE IS HIV VACCINE WHICH PREVENTS YOU UP TO SIX MONTHS?
🟢WHO Endorses Twice-Yearly Injectable Lenacapavir (LEN) as a New Global HIV Prevention Option that was announced on 14 July 2025 in IAS Conference on HIV Science, Kigali, Rwanda
1️⃣As the world marked World AIDS Day on 1st December, we paused to honor the millions of lives affected by HIV/AIDS and reaffirm the global commitment to ending the epidemic.
Despite decades of progress, HIV continues to disproportionately impact vulnerable populations, and prevention efforts have plateaued.
Today, a major scientific development offers renewed hope: a groundbreaking WHO recommendation that could reshape the global HIV prevention landscape.
2️⃣ Lenacapavir (LEN): is the Transformative Prevention Innovation, Lenacapavir is the first long-acting injectable PrEP taken only twice per year, representing a significant expansion of HIV prevention tools.
Key advantages of LEN:
☑️Two injections per year ensure sustained protection
☑️Near-complete efficacy demonstrated in clinical trials
☑️Discreet and stigma-reducing, ideal for individuals who cannot take daily pills
☑️Simplifies prevention for people with limited access to regular healthcare services
☑️This innovation provides a flexible and more accessible prevention method tailored to real-world challenges.
☑️FDA approval supporting its safety and efficacy
🟢HIV is still there, remember prevention is the only option to a healthy life.